Blog

3D cell culturing systems offer new methods to evaluate organ activity and close the gap between 2D cell culture and animal models

Prediction of patient response to treatment by testing on tissue outside of patients body

In vitro brain organoids lead to improved research avenues. They allow scientists to develop biologically appropriate microenvironments

The study of inflammatory bowel disease (IBD) can be challenging due to the lack of human models. Intestinal organoids generated from patient tissue can be used to develop personalized therapies.

Common colon cancer treatments include surgical procedures, radiation therapy, and systemic chemotherapy and immunotherapy. There is a need for more personalized treatment options for improving results from colon cancer therapies and reducing the chance of reoccurrence.

Colorectal Cancer (CRC) studies mostly involve animal models, but 3D organoid models provide a promising alternative as they better recapitulate disease conditions and cancer environments in humans

PerfusionPal 3D is a MPS platform that enables growth and screening of 3D mono-cultures with perfusion. PerfusionPal can be used to predict liver toxicity caused by a drug early in the development process.

Precision medicine uses a personalized and outcomes-based approach to address differences in society by tailoring treatments to individual patients and their specific disease

Brain organoids, which model various cell types in different regions of the brain, are promising models for the future of neurological research and drug development

Breast cancer research using Cellevate's 3D nanofibers may be a useful 3D scaffold that mimics the tutor microenvironment for use in the 3D culture of breast cancer cells in preclinical studies

Using patient-derived cells to closely mimic brain function, brain organoids mimic brain function and elucidate the molecular basis of disease for personalized medicine